Neurodiagnostics Market Will Grow at Highest Pace Owing to Rising Prevalence of Neurological Disorde
Author : Raj Dhote | Published On : 18 Apr 2024
The neurodiagnostics market involves diagnostic tools and devices used to identify central and peripheral nervous system disorders. Some common neurodiagnostic tools include diagnostic imaging systems such as MRI, CT, PET, EEG, and EMG. Neurological disorders severely impact quality of life and are a huge economic burden. Various advantages offered by neurodiagnostic tools include non-invasive procedures, identification of abnormalities early, and monitoring disease progression. The increasing prevalence of neurological conditions such as stroke, Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis is driving the demand for neurodiagnostic devices globally.
The Global neurodiagnostics market is estimated to be valued at US$ 14.91 billion in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the Neurodiagnostics Market Demand are Koninklijke Philips N.V, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corporation, Bio-Rad Laboratories Inc. Neurodiagnostic devices help in early and accurate diagnosis of neurological disorders. The growing geriatric population which is more susceptible to neurological conditions is fueling the demand for neurodiagnostic devices. Furthermore, technological advancements are enabling high resolution brain imaging, physiological signal monitoring, and non-invasive diagnostic procedures.
Growing demand is attributable to rising disease burden of neurological disorders worldwide. According to the WHO, over 1 billion people suffer from neurological disorders globally. Estimates indicate 50 million strokes and over 50 million epilepsy cases occur worldwide every year. With growing awareness and improved access to healthcare, the demand for effective neurodiagnosis and treatment is rising significantly.
Technological developments are further strengthening the potential of neurodiagnostic devices. Newer imaging techniques such as high resolution MRI and PET scans provide precise anatomical and functional details. Wearable EEG devices and sensors enable long term ambulatory monitoring of brain signals. AI and machine learning are finding increased usage for automated image analysis and diagnostics.
Market Trends
1. Portable and wearable neurodiagnostic devices: Major players are developing portable and wearable devices for easy use in homecare settings and remote patient monitoring.
2. Digital biomarkers: Digital platforms are being used to capture digital biomarkers from clinical tests, wearing, and ambient sensing for neurology. This enables remote and continuous monitoring.
Market Opportunities
1. Emerging economies: Developing countries in Asia Pacific and Latin America offer high growth opportunities owing to increasing healthcare expenditure and demand for improved neurological care.
2. Integration with telehealth: Neurologists are increasingly relying on telehealth and virtual consultations. Integration of neurodiagnostics devices with telehealth platforms can revolutionize access to specialty care.
Impact of COVID-19 on Neurodiagnostics Market Growth
The COVID-19 pandemic has significantly impacted the growth of the global neurodiagnostics market. During the initial outbreak of the virus, many elective diagnostic procedures and neurology office visits were postponed to focus on COVID-19 treatment. This led to a decline in the demand for neurodiagnostics devices and services. However, as the pandemic progressed, neurological complications associated with COVID-19 infections such as acute ischemic stroke, intracerebral hemorrhage, encephalopathy etc increased demand for neuroimaging and electrodiagnostic testing. Studies found that neurological symptoms like headache, impaired consciousness and muscle injury were commonly reported in COVID-19 patients.
Furthermore, many regions witnessed a backlog of pre-COVID neurological cases that required attention. Several healthcare centers and clinics adapted to new protocols for non-COVID neurology care to address this growing patient load safely. Telehealth and remote monitoring solutions saw higher adoption to minimize physical contact. Home-use devices for conditions like epilepsy and sleep disorders also gained importance. Going forward, long-term neurological sequelae of COVID-19 infections may persist and drive the need for innovative diagnostic tools and decentralized care approaches. Vaccination programs are expected to curb future outbreaks and help neurodiagnostics market return to its pre-pandemic growth trajectory over the forecast period.
Geographical Concentration of Neurodiagnostics Market
In terms of value, North America dominates the global neurodiagnostics market and accounted for the largest share of over 40% in 2024 led by the United States. This can be attributed to factors such as the rising geriatric population, high healthcare spending, availability of advanced testing options and encouraging reimbursement policies in the region. Additionally, ongoing clinical research on neuromonitoring, neurodegenerative disorders and new biomarker discovery in countries like the U.S. also fuel market growth.
Europe is the second largest regional neurodiagnostics market supported by growing awareness about neurological illnesses and rising adoption of advanced equipment across major countries like Germany, United Kingdom and France. Asia Pacific is poised to be the fastest growing market in the coming years. Expanding healthcare infrastructure, heavy government investments and booming medical tourism industry are some key factors driving the APAC neurodiagnostics space. China and India specifically demonstrate high potential for neurotechnology with their vast patient pools and rising disposable incomes. Improving access to diagnostics will be an area of focus in emerging economies to better address their neurology burden.
Fastest Growing Region in the Neurodiagnostics Market
Asia Pacific region is projected to witness the fastest growth over the forecast period in the global neurodiagnostics market. Factors such as rapidly aging populations, increasing incidence of neurological disorders, growing medical capabilities and rising health expenditures are driving broader availability and adoption of neurodiagnostic care across major APAC countries.
National programs supporting healthcare modernization and digital transformation also create favorable conditions for neurotechnology providers. Penetration of portable, non-invasive devices for neurovascular, neurodegenerative and sleep evaluations which overcome resource limitations have seen strong adoption. Private sector investments as well as collaborations between local manufacturers and global leaders are enhancing the accessibility and affordability of neurodiagnostics. Regulatory reforms and public insurance schemes are expanding coverage and helping tackle cost barriers. With ongoing economic development, Asia Pacific's sizable patient pool and risk factor burden positions it as an area of huge untapped market potential for the years ahead.
Get more insights, On Neurodiagnostics Market
